Please use this identifier to cite or link to this item:
Title: The long-term impact of beta-lactam antibiotic allergy testing - A matched case-control study.
Austin Authors: Trubiano, Jason A ;Marhoon, Nada ;Vogrin, Sara;Chua, Kyra Y L ;Holmes, Natasha E 
Affiliation: Centre for Antibiotic Allergy and Research
Data Analytics Research and Evaluation (DARE) Centre
Medicine (University of Melbourne)
Infectious Diseases
Centre for Integrated Critical Care, University of Melbourne, Melbourne, Australia
The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia
Issue Date: 28-Sep-2020 2020-09-28
Publication information: Antimicrobial Agents and Chemotherapy 2020; online first: 28 September
Abstract: Whilst the short-term impact of antibiotic allergy testing on delabeling and antibiotic usage have been demonstrated, the long-term impact have been less well defined. In a single centre matched case control study from Melbourne (Australia), we demonstrate a beta-lactam antibiotic allergy testing program has a significant impact on antibiotic usage and infection-related outcomes. This study supports the implementation of antibiotic allergy testing program (AAT) as a standard of care of antimicrobial stewardship (AMS) programs.
DOI: 10.1128/AAC.01823-20
ORCID: 0000-0002-5111-6367
Journal: Antimicrobial Agents and Chemotherapy
PubMed URL: 32988819
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jun 9, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.